TP53 and thyroid gland carcinoma: The present observations in PDTC suggest that once the thyroid cancer reaches a poorly differentiated state exhibiting a mutant p53 and TERT-p mutation, the ability to respond to DDR is lost, leading to a decreased 53BP1 expression.